Hyperchloremic, normal anion-gap, metabolic acidosis due to topiramate

American Journal of Health-System Pharmacy

Volumn 65, Issue 15, 2008, Pages 1430-1434

  Mathews, Kathryn D ^a,b   Stark, Jennifer E ^b  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Acidosis; Anticonvulsants; Cefotaxime; Dosage; Patient information; Topiramate; Toxicity

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BICARBONATE; CARBAMAZEPINE; CARBONATE DEHYDRATASE; CEFOTAXIME; FERROUS SULFATE; LAMIVUDINE; LOPINAVIR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; POTASSIUM CHLORIDE; PROMETHAZINE; RANITIDINE; RITONAVIR; TOPIRAMATE; VALPROIC ACID; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANION GAP; ARTICLE; BICARBONATE BLOOD LEVEL; CASE REPORT; CEREBROVASCULAR ACCIDENT; CHLORIDE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG MECHANISM; DRUG WITHDRAWAL; HOSPITAL ADMISSION; HUMAN; HYPERCHLOREMIC ACIDOSIS; MALE; METABOLIC ACIDOSIS; PATIENT COUNSELING; PATIENT MONITORING; PNEUMONIA; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK ASSESSMENT; RISK FACTOR; SEIZURE;

EID: 49449111187     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070395     Document Type: Article

References (23)

1. Product information. Topiramate (Topamax). Titusville, NJ: Ortho-McNeil; rev. 2007 Mar.
2. DRUGDEX System. Greenwood Village, CO: Thomson Micromedex (accessed 2007 Apr).
3. Johnson and Johnson 2006 annual report. http://jnj.vl.papiervirtuel.com/ report/2007030901/ (accessed 2007 Jun 20).
4. Philippi H, Boor R, Reitter B. Topiramate and metabolic acidosis in infants and toddlers. Epilepsia. 2002; 43:744-7.
5. Takeoka M, Holmes GL, Thiele E et al. Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia. 2001; 42:387-92.
6. Tartara A, Sartori I, Manni R et al. Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial. Ital J Neurol Sci. 1996; 17:429-32.
7. Wilner A, Raymond K, Pollard R. Topiramate and metabolic acidosis. Epilepsia. 1999; 40:792-5.
8. Stowe CD, Bollinger T, James LP et al. Acute mental status changes and hyperchloremic metabolic acidosis with long-term topiramate therapy. Pharmacotherapy. 2000; 20:105-9.
9. Ozer Y, Altunkaya H. Topiramate induced metabolic acidosis. Anaesthesia. 2004; 59:830. Letter.
10. Burmeister JE, Pereira RR, Hartke EM et al. Topiramate and severe metabolic acidosis: case report. Arq Neuropsiquiatr. 2005; 63:532-4.
11. Sacré A, Jouret F, Manicourt D et al. Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase. Nephrol Dial Transplant. 2006; 21:2995-6.
12. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
13. Shank RP, Gardocki JF, Vaught JL et al. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia. 1994; 35:450-60.
14. Rho JM, Sankar R. The pharmacologic basis of antiepileptic drug reaction. Epilepsia. 1999; 40:1471-83.
15. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia. 2000; 41:S35-9.
16. Gibbs JW, Sombati S, DeLorenzo RJ et al. Cellular actions of topiramate: blockade of kainite-evoked inward currents in cultured hippocampal neurons. Epilepsia. 2000; 41:S10-6.
17. DeLorenzo RJ, Sombati S, Coulter DA. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia. 2000; 41:S40-4.
18. White HS, Brown SD, Woodhead JH et al. Topiramate enhances GABA-medicated chloride flux and GABA-evoked currents in mouse brain neurons and increases seizure threshold. Epilepsy Res. 1997; 28:167-79.
19. Montenegro MA, Guerreiro MM, Scotoni AE et al. Predisposition to metabolic acidosis induced by topiramate. Arq Neurop-siquiatr. 2000; 58:1021-4.
20. Pasternack M, Voipio J, Kaila K. Intracellular carbonic anhydrase activity and its role in GABA-induced acidosis in isolated rat hippocampal pyramidal neurons. Acta Physiol Scand. 1993; 148: 229-31.
21. 2 on excitatory transmission apparently caused by changes in intracellular pH in the rat hippocampal slice. Brain Res. 1996; 706:210-6.
22. Taira T, Lamsa K, Kaila K. Posttetanic excitation mediated by GABA(A) receptors in rat CA1 pyramidal neurons. J Neurophysiol. 1997; 77:2213-318.
23. Staley KJ, Soldo BL, Proctor WR. Ionic mechanisms of neuronal excitation by inhibitory GABA(A) receptors. Science. 1995; 269:977-81.